[The cellular immunity indices in diabetic nephropathy]

Area of Science:

• Immunology
• Nephrology
• Endocrinology

Background:

• Diabetes mellitus (DM) is a chronic condition with potential kidney complications.
• Diabetic nephropathy (DN) is a significant microvascular complication of DM.
• Understanding immune system involvement in early DN is crucial for intervention.

Purpose of the Study:

• To investigate lymphocyte subpopulations and activation markers in pre-nephrotic DN.
• To assess serum neopterin levels as a marker of cellular immunity activation in DN.
• To explore the potential pathogenetic role of activated lymphocytes in DN.

Main Methods:

• Analyzing peripheral blood mononuclear cells from 15 pre-nephrotic DN patients and 19 DM patients without DN.
• Using indirect immunofluorescence with monoclonal antibodies (CD3, CD4, CD8, CD22, CD25, CD71, HLA-DR).
• Measuring serum neopterin levels via radioimmunoassay.

Main Results:

• Pre-nephrotic DN patients had normal levels of major lymphocyte subpopulations (CD3, CD4, CD8, CD22).
• DN was associated with increased expression of activation markers (CD25, HLA-DR) on mononuclear cells.
• Serum neopterin concentrations were elevated in patients with pre-nephrotic DN.

Conclusions:

• The pre-nephrotic stage of DN is characterized by immune cell activation, not changes in main lymphocyte counts.
• Increased neopterin and activated lymphocyte markers suggest a role for cellular immunity in DN pathogenesis.
• Activated lymphocytes may damage glomerular basal membranes via endoglycosidase production, impairing kidney function.